Rx DRUG COSTS: Maine Takes A Stab at Curbing Prices
Addressing inequities in access to life-saving, but costly, prescription drugs is a key area of contention in both the Congress and on the presidential debate trail. But Maine is not waiting for the feds to get their act together. As California Healthline's Jeff Stryker reports, the Pine Tree state is out in front with a new law to curb drug prices. Is it the answer to the prayers of the underinsured or to those worried about creeping socialism?
California Healthline Features is a regular Monday column in California Healthline. Columnists Jeff Stryker and Stephen Robitaille take readers behind the headlines, with in-depth articles, guest editorials and interviews with California newsmakers. Click here for more on the column.
The views represented in this column are those of the columnist or guest editorialist and not of California Healthline or the National Journal Group.